Nucleolar stress: Friend or foe in cardiac function?

被引:2
|
作者
Yan, Daliang [1 ]
Hua, Lu [2 ]
机构
[1] Taizhou Peoples Hosp, Dept Cardiovasc Surg, Taizhou, Peoples R China
[2] Taizhou Peoples Hosp, Dept Oncol, Taizhou, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
nucleolus; nucleolar stress; cardiac disease; nucleostemin; nucleophosmin; nucleolin; senescence; POLYMERASE-I TRANSCRIPTION; FACTOR TIF-IA; RIBOSOMAL-RNA SYNTHESIS; DNA-DAMAGE; PREMATURE SENESCENCE; HEART-FAILURE; NUCLEOSTEMIN; ACTIVATION; BIOGENESIS; PROTEIN;
D O I
10.3389/fcvm.2022.1045455
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Studies in the past decades have uncovered an emerging role of the nucleolus in stress response and human disease progression. The disruption of ribosome biogenesis in the nucleolus causes aberrant nucleolar architecture and function, termed nucleolar stress, to initiate stress-responsive pathways via nucleolar release sequestration of various proteins. While data obtained from both clinical and basic investigations have faithfully demonstrated an involvement of nucleolar stress in the pathogenesis of cardiomyopathy, much remains unclear regarding its precise role in the progression of cardiac diseases. On the one hand, the initiation of nucleolar stress following acute myocardial damage leads to the upregulation of various cardioprotective nucleolar proteins, including nucleostemin (NS), nucleophosmin (NPM) and nucleolin (NCL). As a result, nucleolar stress plays an important role in facilitating the survival and repair of cardiomyocytes. On the other hand, abnormalities in nucleolar architecture and function are correlated with the deterioration of cardiac diseases. Notably, the cardiomyocytes of advanced ischemic and dilated cardiomyopathy display impaired silver-stained nucleolar organiser regions (AgNORs) and enlarged nucleoli, resembling the characteristics of tissue aging. Collectively, nucleolar abnormalities are critically involved in the development of cardiac diseases.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Cardiac fibroblasts: friend or foe?
    Baudino, Troy A.
    Carver, Wayne
    Giles, Wayne
    Borg, Thomas K.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2006, 291 (03): : H1015 - H1026
  • [2] Function and Flexibility: Friend or Foe?
    Pauwels, Kris
    Tompa, Peter
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2016, 3
  • [3] Cardiac SK channels: Friend or foe?
    Grunnet, Morten
    HEART RHYTHM, 2015, 12 (05) : 1016 - 1017
  • [4] Stress ulcer prophylaxis: friend or foe?
    MacDonald, J. J.
    Roberts, J. C.
    Washington, S.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2012, 73 (04) : 238 - 238
  • [5] RESIDUAL STRESS: BOTH FRIEND AND FOE
    Furrer, David
    ADVANCED MATERIALS & PROCESSES, 2020, 178 (06): : 29 - 34
  • [6] Mitochondrial stress: Balancing friend and foe
    Runkel, Eva Diana
    Baumeister, Ralf
    Schulze, Ekkehard
    EXPERIMENTAL GERONTOLOGY, 2014, 56 : 194 - 201
  • [7] Nutrients and Oxidative Stress: Friend or Foe?
    Tan, Bee Ling
    Norhaizan, Mohd Esa
    Liew, Winnie-Pui-Pui
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2018, 2018
  • [8] Cardiac troponin - Friend of the cardiac physician, foe to the cardiac patient?
    Wu, Alan H. B.
    CIRCULATION, 2006, 114 (16) : 1673 - 1675
  • [9] Leptin and vascular function: friend or foe?
    Wolk, Robert
    Somers, Virend K.
    EUROPEAN HEART JOURNAL, 2006, 27 (19) : 2263 - 2265
  • [10] PAI-1: cardiac friend or foe?
    Miles, Lindsey A.
    Parmer, Robert J.
    BLOOD, 2010, 115 (10) : 1862 - 1863